MANILA, Philippines 鈥 The Philippines and Japan have formalized a P14-billion loan that will support Manila鈥檚 COVID-19 vaccination and economic recovery from the pandemic.
Department of Foreign Affairs (DFA) Undersecretary Lourdes Yparraguirre and Japanese Ambassador to the Philippines Koshikawa Kazuhiko on Monday signed and exchanged notes on COVID-19 Crisis Response Emergency Support Loan Phase-2 (CCRESL Phase-2).
This augments an earlier loan package from Japan amounting to 50 billion yen in July 2020.
鈥淭he latest loan package supports the Philippines鈥 efforts to recover from the economic impacts of COVID-19, and build public health and economic resilience against such future emergencies,鈥 the DFA said in a statement.
The new loan amounts to 30 billion yen (approximately P14 billion) and 鈥渟eeks to support the Philippine government鈥檚 efforts in promoting COVID-19 vaccination and ensuring the steadfast economic recovery in the post-COVID-19 era by providing budgetary support,鈥 the Japanese embassy said in a separate statement.
鈥淯nder highly concessional terms, the loan鈥檚 repayment period is set to 11 years after a grace period of 4 years, with a fixed interest rate of 0.01% per annum,鈥 it added.
According to the embassy, the first phase of the loan was provided to the Philippines in July 2020.
鈥淭he Philippine government was the very first recipient of this highly concessional loan specifically designed by the Japanese government to address the global health crisis. CCRESL Phase-2 is the second loan support provided to the Philippines,鈥 it added.
鈥淛apan has continuously provided comprehensive support to the Philippines since the COVID-19 pandemic,鈥 the embassy further said.
On top of 鈥渂ig-ticket yen loan assistance鈥 through the CCRESL and the Post-Disaster Standby Loan, the embassy cited that its support to the Philippines鈥 fight against the pandemic also includes a donation of over 3 million COVID-19 vaccine doses, grant aid for the procurement of medical equipment and establishment of laboratory surveillance sites, and technical assistance for cold chain development as well as the provision of Avigan tablets for COVID-19 treatment.
RELATED STORY